Glottic versus supraglottic tumors: Differential molecular profile

European Archives of Oto-Rhino-Laryngology

Volumn 265, Issue 1, 2008, Pages 79-84

  Kourelis, Konstantinos ^a,b,d   Papadas, Theodoros ^a   Vandoros, Gerasimos ^b,c   Goumas, Panos ^a   Sotiropoulou Bonikou, Georgia ^b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c General Hospital of Aegion   (Greece)

^d NONE   (Greece)

Author keywords

COX 2; EGFR; Laryngeal subsite; NF B; RXR ; Squamous cell carcinoma

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARAFFIN; RETINOID X RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; FEMALE; GLOTTIS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NF-KAPPA B; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINOID X RECEPTORS;

EID: 36348978032     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-007-0441-7     Document Type: Article

References (32)

1. Cattaruzza MS, Maisonneuve P, Boyle P (1996) Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol 32B:293-305
2. Adams G, Maisel R (2005) Malignant tumors of the larynx and laryngopharynx. In: Cummings C (ed) Cummings otolaryngology head and neck surgery, 4 edn. Mosby, Philadelphia, pp 2222-2283
3. Rosai J (1996) Larynx and trachea. In: Rosai J, Ackerman LV (eds) Ackerman's surgical pathology, 8 edn. Mosby, Philadelphia, pp 314-331
4. Cotran R, Kumar V, Robbins S (1998) Head and neck. In: Schoen F (ed) Robbins pathologic basis of disease, 5 edn. Saunders, Philadelphia, pp 735-753
5. De Stefani E, Boffetta P, Deneo-Pellegrini H, Brennan P, Correa P, Oreggia F, Ronco AL, Mendilaharsu M (2004) Supraglottic and glottic carcinomas: epidemiologically distinct entities? Int J Cancer 112:1065-1071
6. Raitiola H, Pukander J, Laippala P (1999) Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis. Acta Otolaryngol 119:847-851
7. Putti TC, To KF, Hsu HC, Chan AT, Lai GM, Tse G, Lee YS, Whang-Peng J, Millward M, Lin L, Lin X, Lee CS (2002) Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region. Histopathology 41:144-151
8. Shishodia S, Aggarwal BB (2004) Nuclear factor-kappaB: a friend or a foe in cancer? Biochem Pharmacol 68:1071-1080
9. Tamatani T, Azuma M, Aota K, Yamashita T, Bando T, Sato M (2001) Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells. Cancer Lett 171:165-172
10. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ et al (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323:795-801
11. Rastinejad F (2001) Retinoid X receptor and its partners in the nuclear receptor family. Curr Opin Struct Biol 11:33-38
12. Subbaramaiah K, Dannenberg AJ (2003) Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 24:96-102
13. Sobin L, Wittekind C (2002) TNM classification of malignant tumors. Wiley, New York
14. Krecicki T, Jelen M, Zalesska-Krecicka M, Rak J, Szkudlarek T, Jelen-Krzeszewska J (1999) Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol 35:180-186
15. Bindhu OS, Ramadas K, Sebastian P, Pillai MR (2006) High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Head Neck 28:916-925
16. Bayazit YA, Buyukberber S, Sari I, Camci C, Ozer E, Sevinc A, Karakok M, Kanlikama M, Mumbuc S (2004) Cyclo-oxygenase 2 expression in laryngeal squamous cell carcinoma and its clinical correlates. ORL J Otorhinolaryngol Relat Spec 66:65-69
17. Kourelis K, Sotiropoulou-Bonikou G, Vandoros G, Repanti M, Varakis I, Goumas P (2007) Coordinated Upregulation of COX-2 and NF-kappaB Is a Steady Feature of Laryngeal Carcinogenesis. ORL J Otorhinolaryngol Relat Spec 69:181-189
18. Xu XC, Wong WY, Goldberg L, Baer SC, Wolf JE, Ramsdell WM, Alberts DS, Lippman SM, Lotan R (2001) Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res 61:4306-4310
19. Kurie JM, Shin HJ, Lee JS, Morice RC, Ro JY, Lippman SM, Hittelman WN, Yu R, Lee JJ, Hong WK (1996) Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. Clin Cancer Res 2:1787-1793
20. Boisvieux-Ulrich E, Le Pechon-Vallee C, Million K, Baeza-Squiban A, Houcine O, Guennou C, Reichert U, Marano F (2000) Differential effects of several retinoid receptor-selective ligands on squamous differentiation and apoptosis in airway epithelial cells. Cell Tissue Res 300:67-81
21. Brabender J, Metzger R, Salonga D, Danenberg KD, Danenberg PV, Holscher AH, Schneider PM (2005) Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. Carcinogenesis 26:525-530
22. O-charoenrat P, Rhys-Evans PH, Modjtahedi H, Eccles SA (2002) The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma. Oral Oncol 38:627-640
23. Leong JL, Loh KS, Putti TC, Goh BC, Tan LK (2004) Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope 114:153-157
24. Smid EJ, Stoter TR, Bloemena E, Lafleur MV, Leemans CR, van der WaI, Slotman BJ, Langendijk JA (2006) The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 65:1323-1329
25. Arteaga CL (2002) Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7(Suppl 4):31-39
26. Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, Gooding WE, Furnari FB, Grandis JR (2006) Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res 12:5064-5073
27. Grandis JR, Tweardy DJ (1993) Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579-3584
28. Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR (2001) Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines. Cancer Res 61:5919-5925
29. Tian B, Brasier AR (2003) Identification of a nuclear factor kappa B-dependent gene network. Recent Prog Horm Res 58:95-130
30. Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T (1995) Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 270:24965-24971
31. Choong NW, Cohen EE (2006) Epidermal growth factor receptor directed therapy in head and neck cancer. Crit Rev Oncol Hematol 57:25-43
32. Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM (2004) Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Clin Cancer Res 10:5930-5939